Rossari Biotech - Quaterly Results

The Revenue for the quarter ended  December 2025 of Rs. 4506.58 millions grew by 22.37 % from Rs. 3682.78 millions.A slender decline of -0.02% was recorded to Rs. 306.26  millions from Rs. 306.31 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 515.22 millions from 509.66 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202512	202412	% Var	202512	202412	% Var	202503	202403	% Var
Sales	4506.58	3682.78	22.37	12359.28	10049.75	22.98	14316.28	12029.10	19.01
Other Income	11.41	10.06	13.42	42.80	33.46	27.91	57.42	67.71	-15.20
PBIDT	515.22	509.66	1.09	1490.17	1373.81	8.47	1919.77	1680.25	14.26
Interest	39.53	22.78	73.53	95.39	65.09	46.55	95.84	97.02	-1.22
PBDT	475.69	486.88	-2.30	1394.78	1308.72	6.58	1823.93	1583.23	15.20
Depreciation	74.69	74.26	0.58	219.62	200.27	9.66	276.90	241.89	14.47
PBT	401.00	412.62	-2.82	1175.16	1108.45	6.02	1547.03	1341.34	15.33
TAX	94.74	106.31	-10.88	294.08	284.67	3.31	399.61	344.89	15.87
Deferred Tax	-10.46	-8.43	24.08	-19.89	-13.68	45.39	-22.25	-16.70	33.23
PAT	306.26	306.31	-0.02	881.08	823.78	6.96	1147.42	996.45	15.15
Equity	110.76	110.71	0.05	110.76	110.71	0.05	110.73	110.49	0.22
PBIDTM(%)	11.43	13.84	-17.39	12.06	13.67	-11.80	13.41	13.97	-4.00